Alistair Capital Management, L.L.C. - CARDIOME PHARMA CORP ownership

Quarter-by-quarter ownership
Alistair Capital Management, L.L.C. ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q2 2014$1,695,000
-61.9%
215,900
-61.6%
1.00%
-44.6%
Q1 2014$4,451,000
-22.1%
562,700
-38.7%
1.80%
-29.7%
Q4 2013$5,715,000917,4002.56%
Other shareholders
CARDIOME PHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,195,692$4,953,0002.97%
Tamarack Advisers, LP 1,875,000$2,906,0001.59%
CLOUGH CAPITAL PARTNERS L P 2,667,585$4,135,0000.34%
Rock Springs Capital Management LP 1,200,000$1,860,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,678,364$7,251,0000.06%
KNOTT DAVID M 67,978$105,0000.04%
PUTNAM INVESTMENTS LLC 6,184,266$9,586,0000.01%
AlphaOne Investment Services, LLC 10,625$16,0000.01%
A.R.T. Advisors, LLC 34,872$54,0000.00%
Virtu Financial LLC 11,693$18,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders